Fee-Related Earnings (FRE): Record $311 million, up 17% year-over-year. FRE Margin: Record 48%. Distributable Earnings (DE): Record $455 million. Assets Under Management (AUM): Record $453 billion, up 6% year-over-year. Inflows: $50 billion over the past year, including $14 billion in the first quarter. Carlyle AlpInvest FRE: $66 million, nearly double from the first quarter of 2024. Global Credit Revenue: $232 million, up 28% year-over-year. Global Credit Inflows: $7.5 billion in the first quarter. Transaction Fees: More than tripled compared to the same period last year. US Buyout Strategies Capital Returned: Nearly $8 billion over the past year. Firm-wide Capital Returned: $31 billion, more than 40% higher than the prior 12-month period. Evergreen Strategies AUM: $26 billion, up 27% over the past year. Warning! GuruFocus has detected 5 Warning Signs with CG. Release Date: May 08, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points The Carlyle Group Inc (NASDAQ:CG) reported record fee-related earnings of $311 million, up 17% year-over-year. The company achieved a record FRE margin of 48% and the highest level of distributable earnings in several years at $455 million. Assets under management reached a record $453 billion, indicating strong growth and expansion. Carlyle AlpInvest generated record FRE in the first quarter, nearly double the first quarter last year, with AUM growing 12% to a record $89 billion. Global Credit's quarterly fee-related earnings surpassed $100 million for the first time, an increase of nearly 50% from last year, driven by significant demand for private credit solutions. Negative Points The macroeconomic environment remains uncertain, with trade policies and tariffs impacting investor sentiment and risk appetite. The long-term effects of trade policy are difficult to forecast, creating uncertainty in the market. The private equity market is facing headwinds, which could affect Carlyle's corporate PE franchise over the next 12 to 18 months. There is potential stress in the endowment sector, which could impact future fundraising if endowments slow investments in private markets. Market conditions remain dynamic, and while Carlyle is built to perform across cycles, the situation is fluid and the market backdrop is uncertain. Q & A Highlights Q: Can you discuss the impact of trade policy and tariffs on your global portfolio and how it affects LP discussions? A: Harvey Schwartz, CEO: We entered the year with high expectations, but the tariff policy implementation caught many off guard. The administration has since clarified its approach, which has improved sentiment. Discussions with LPs are cautiously optimistic, with many looking for opportunities to deploy capital. The main concern remains the US-China trade dialogue, as prolonged tensions could negatively impact the global economy. Story Continues Q: How do you view the corporate Private Equity (PE) franchise over the next 12 to 18 months, especially regarding CP IX? A: Harvey Schwartz, CEO: We don't anticipate major changes in timing for CP IX, which will depend on our pace of deployment. Our teams have been active in returning capital, and our US Buyout business is performing well. We expect some headwinds in the PE market, but our scale and diversification help us navigate these challenges. Q: How should we think about the insurance wins relative to your $40 billion flow guide for the year? A: John Redett, CFO: The $40 billion flow guide includes the insurance wins. We've seen strong performance in wealth, with fundraising up 40% and Evergreen products up 70% year-over-year. Post-trade policy shift, we haven't seen any data that gives us pause, and April was a good month. Q: Can you elaborate on the opportunity set in Japan across your business? A: Harvey Schwartz, CEO: Japan is a dynamic market, and we have a strong presence there, celebrating our 20th anniversary. The demand for LP interest and opportunities continues to grow. We're leveraging our brand in wealth platforms and insurance, and our long-standing role in the region positions us well for future growth. Q: How should we think about the triggers for CP VII to start generating cash carry? A: John Redett, CFO: It's hard to predict exactly when a carry fund hits full carry, but CP VII is on that path. The fund's performance continues to improve, and we have a strong pipeline of realization activity. We expect it to hit full carry within the next 12 months. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
The Carlyle Group Inc (CG) Q1 2025 Earnings Call Highlights: Record Growth Amid Market Uncertainty
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...